Cure Logo

April 30, 2024

AI and Machine Learning

AI & The Future of Cures

Introduction

Xchange Challenge winners and co-founders Grant W. Mitchell MD, MBA, and David Fajgenbaum, MD, MBA, MSc from Every Cure join Tuesday Talks. Learn about their groundbreaking AI-powered platform that offers solutions for rare disease treatments and cures—a capability beyond the reach of many medical experts today. We'll delve into how their $48.3 million government grant will be fueling meaningful advancements, Dr. Fajgenbaum's personal victory over his rare disease, and the company's patient-first approach at their new Cure NYC headquarters.

More about this topic

Spotlight On: Grant Mitchell, MD, MBA, CEO and Co-founder of Every Cure

Grant Mitchell, MD, MBA, and his co-founder are on a mission to use AI to match drugs already on the market with diseases that currently have no cure.

Xchange StoryFeb 20, 2024